Influx Healthtech Limited (NSE:INFLUX)

Market Cap	5.32B
Revenue (ttm)	1.24B +62.5%
Net Income	177.56M +146.7%
EPS	9.11 +130.0%
Shares Out	23.15M
PE Ratio	25.21
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,200
Average Volume	26,850
Open	225.00
Previous Close	222.40
Day's Range	224.00 - 234.35
52-Week Range	120.00 - 261.95
Beta	n/a
RSI	55.87
Earnings Date	Feb 4, 2026

About Influx Healthtech

Influx Healthtech Limited operates as a contract development and manufacturing organization that provides a range of healthcare products in India. The company offers ayurvedic and herbal formulations in form of tablets, capsules, powders, liquid orals, ointments, creams, lotions, and other applications; veterinary feed supplements in form of tablets, liquid orals, oral sprays, powders, bolus, gels, ointments, and creams for animals; and home care products, including bathroom cleaners, floor cleansers, phenyle liquids, and other household cleani...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2003
• Employees: 163
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: INFLUX

Financial Performance

In fiscal year 2025, Influx Healthtech's revenue was 1.05 billion, an increase of 4.89% compared to the previous year's 999.65 million. Earnings were 133.66 million, an increase of 20.11%.